Publications by authors named "C Estoppey"

Claim this Profile
I
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.
Laura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, Daniela Pais, Carole Estoppey

Nat Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative splicing for tuneable expression of protein subunits at desired ratios.
Christel Aebischer-Gumy, Pierre Moretti, Timothee Brunstein Laplace, Jana Frank, Ysaline Grand, Carole Estoppey

MAbs· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.
C Grandclément, C Estoppey, E Dheilly, M Panagopoulou, T Monney

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.
Blandine Pouleau, Carole Estoppey, Perrine Suere, Emilie Nallet, Amélie Laurendon

Blood· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of homogeneous cell populations with tunable levels of transgene expression.
Dominique Schlicht, Carole Estoppey, Julie Macoin, Blandine Pouleau, Martin Bertschinger

J Biotechnol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis